Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimin Capsule in Perennial Allergic Rhinitis (Lung–Kidney Yang Deficiency)
CTR20212552Phase 2Completed
- Sponsor
- Jinan Kangzhong Pharmaceutical Technology Development
- Start
- Dec 2021
- Countries
- 1
01
Overview
A Phase 2 trial of bimin in allergic rhinitis (AR), sponsored by Jinan Kangzhong Pharmaceutical Technology Development. Started Dec 2021; status: completed.
02
Drugs
bimin
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20212552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212552.